Avalyn Pharma Inc. Common Stock (AVLN) — Long-term Investment Intensity
Avalyn Pharma Inc. Common Stock (AVLN) has a Long-term Investment Intensity of 14.4% as of June 2026. Long-term investments of $61.10 Million represent 14.4% of total assets of $425.45 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AVLN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Avalyn Pharma Inc. Common Stock Long-term Investment Intensity (2024–2024)
This chart shows how Avalyn Pharma Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of June 2026, the intensity stands at 14.4%, reflecting long-term investments of $61.10 Million against total assets of $425.45 Million USD. For the complete balance sheet picture, see Avalyn Pharma Inc. Common Stock balance sheet assets.
Annual Long-term Investment Intensity for Avalyn Pharma Inc. Common Stock (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Avalyn Pharma Inc. Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Avalyn Pharma Inc. Common Stock carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 6.0% | $7.49 Million | $124.52 Million | — |